Mechanisms of cough

Current Opinion in Allergy and Clinical Immunology

Volumn 14, Issue 1, 2014, Pages 55-61

  Gibson, Peter G ^a,b   Simpson, Jodie L ^a   Ryan, Nicole M ^a   Vertigan, Anne E ^a,b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b JOHN HUNTER HOSPITAL   (Australia)

Author keywords

cough; eosinophilic bronchitis; laryngeal hypersensitivity; speech pathology

Indexed keywords

CORTICOSTEROID; MONTELUKAST; PROSTAGLANDIN E2; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ANTITUSSIVE AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL;

BRONCHITIS; BRONCHUS; CHRONIC COUGH; DIET; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; EOSINOPHILIC BRONCHITIS; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERSENSITIVITY; LARYNGEAL HYPERSENSITIVITY; LARYNX DISORDER; MEASUREMENT; NERVE TRACT; NEUTROPHILIC BRONCHITIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; QUESTIONNAIRE; RESPIRATORY TRACT ALLERGY; REVIEW; RHINITIS; SENSORY NEUROPATHY; SPEECH THERAPY; VOCAL CORD DISORDER; BRONCHUS HYPERREACTIVITY; COUGH; EOSINOPHIL; IMMUNOLOGY; LARYNX; METABOLISM; MOLECULARLY TARGETED THERAPY; NEUTROPHIL; PATHOLOGY;

ANTITUSSIVE AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHITIS; COUGH; EOSINOPHILS; GASTROESOPHAGEAL REFLUX; HUMANS; LARYNX; MOLECULAR TARGETED THERAPY; NEURAL PATHWAYS; NEUROTRANSMITTER AGENTS; NEUTROPHILS; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84892369661     PISSN: 15284050     EISSN: 14736322     Source Type: Journal    
DOI: 10.1097/ACI.0000000000000027     Document Type: Review

References (43)

1. Richard S, Irwin RS, Michael H, et al. American college of chest physicians (ACCP): Diagnosis and management of cough executive summary ACCP evidence-based clinical practice guidelines. Chest 2006; 129:1S-23S.
2. Morice AH. Chronic cough: Epidemiology. Chron Respir Dis 2008; 5:43-47
3. Lai K, Pan J, Chen R, et al. Epidemiology of cough in relation to China. Cough 2013; 9:18
4. Lai K, Chen R, Lin J, et al. A prospective, multicenter survey on causes of chronic cough in China. Chest 2013; 143:613-620
5. Ojoo JC, Everett CF, Mulrennan SA, et al. Management of patients with chronic cough using a clinical protocol: A prospective observational study. Cough 2013; 9:2
6. Shimizu H, Hayashi M, Saito Y, et al. Classification of chronic cough by systematic treatment cascade trial starting with beta agonist. Cough 2013; 9:4
7. Niimi A, Ohbayashi H, Sagara H, et al. Cough variant and cough-predominant asthma are major causes of persistent cough: A multicenter study in Japan. J Asthma 2013; 50:932-937
8. Chang AB, Robertson CF, van Asperen PP, et al. A cough algorithm for chronic cough in children: A multicenter, randomized controlled study. Pediatrics 2013; 131:e1576-e1583
9. McCrory DC, Coeytaux RR, Yancy WS, et al. Assessment and Management of Chronic Cough. Rockville MD; 2013. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 Jan. Report No.: 13-EHC032-EF. AHRQ Comparative Effectiveness Reviews. An important systematic review of cough evaluation tools
10. Dicpinigaitis PV. Review: Effect of drugs on human cough reflex sensitivity to inhaled capsaicin. Cough 2012; 8:10
11. Purokivi M, Koskela H, Kontra K. Determinants of asthma control and quality of life in stable asthma: Evaluation of two new cough provocation tests. Clin Respir J 2013; 7:253-260
12. Koskela HO, Purokivi MK. Capability of hypertonic saline cough provocation test to predict the response to inhaled corticosteroids in chronic cough: A prospective, open-label study. Cough 2013; 9:15
13. Dicpinigaitis PV, Rhoton WA, Bhat R, Negassa A. Investigation of the urge-to-cough sensation in healthy volunteers. Respirology 2012; 17: 337-341
14. D'silva L, Hassan N, Wang HY, et al. Heterogeneity of bronchitis in airway diseases in tertiary care clinical practice. Can Respir J 2011; 18:144-148
15. Kim YH, Kim KW, Baek J, et al. Usefulness of impulse oscillometry and fractional exhaled nitric oxide in children with Eosinophilic bronchitis. Pediatr Pulmonol 2013; 48:221-228
16. Johnstone KJ, Chang AB, Fong KM, et al. Inhaled corticosteroids for subacute and chronic cough in adults. Cochrane Database Syst Rev 2013; 3:CD009305
17. Gonem S, Raj V, Wardlaw AJ, et al. Phenotyping airways disease: An A to E approach. Clin Exp Allergy 2012; 42:1664-1683
18. Cai C, He MZ, Zhong SQ, et al. Add-on montelukast vs double-dose budesonide in nonasthmatic eosinophilic bronchitis: A pilot study. Respir Med 2012; 106:1369-1375
19. Niimi A. Cough, asthma, and cysteinyl-leukotrienes. Pulm Pharmacol Ther 2013; 26:514-519
20. Takemura M, Niimi A, Matsumoto H, et al. Clinical, physiological and antiinflammatory effect of montelukast in patients with cough variant asthma. Respiration 2012; 83:308-315
21. Lougheed MD, Turcotte SE, Fisher T. Cough variant asthma: Lessons learned from deep inspirations. Lung 2012; 190:17-22
22. Sastre B, Fernández-Nieto M, Ló pez E, et al. PGE(2) decreases muscle cell proliferation in patients with nonasthmatic eosinophilic bronchitis. Prostaglandins Other Lipid Mediat 2011; 95:11-18
23. Sastre B, del Pozo V. Role of PGE2 in asthma and nonasthmatic eosinophilic bronchitis. Mediators Inflamm 2012; 2012:645383
24. Turner MO, Hussack P, Sears MR, et al. Exacerbations of asthma without sputum eosinophilia. Thorax 1995; 50:1057-1061
25. Mcgrath KW, Icitovic N, Boushey HA, et al. A large subgroup of mild-tomoderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185:612-619
26. Simpson JL, Baines KJ, Ryan NM, Gibson PG. Neutrophilic asthma is characterised by increased rhinosinusitis with sleep disturbance and GERD. Asian Pac J Allergy Immunol 2013; in press
27. O'Neill J, Mcmahon SB, Undem BJ. Chronic cough and pain: Janus faces in sensory neurobiology? Pulm Pharmacol Ther 2013; 26:476-485
28. Vertigan AE, Gibson PG. Chronic refractory cough as a sensory neuropathy: Evidence froma reinterpretation of cough triggers. J Voice 2011; 25:596-601
29. Chung KF, Canning B, McGarvey L. The Seventh International Symposium on Cough: Hypertussivity and allotussivity. Pulm Pharmacol Ther 2013; 26:475
30. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory chronic cough: A randomised, double-blind, placebo-controlled trial. Lancet 2012; 380:1583-1589
31. Morice A, McGarvey L, Dicipinigaitis P. Cough hypersensitivity syndrome is an important clinical concept: A pro/con debate. Lung 2011; 190:3-9
32. Vertigan A, Gibson P. The role of speech pathology in the management of patients with chronic refractory cough. Lung 2012; 190:35-40
33. Chamberlain S, Garrod R, Birring S. Cough suppression therapy: Does it work? Pulm Pharmacol Ther 2013; 26:524-527
34. Ryan N, Vertigan A, Bone S, Gibson P. Cough reflex sensitivity improves with speech language pathology management of refractory chronic persistent cough. Cough 2010; 6:5
35. Murry T, Branski R, Yu K, et al. Laryngeal sensory deficits in patients with chronic cough and paradoxical vocal fold movement disorder. Laryngoscope 2010; 120:1576-1581
36. Bonilha HS, Gerlach TT, Sutton LE, et al. Laryngeal sensation before and after clearing behaviors. J Voice 2012; 26:674.e1-674.e77
37. Vertigan AE, Bone SL, Gibson PG. Laryngeal sensory dysfunction in laryngeal hypersensitivity syndrome. Respirology 2013; 18:948-956
38. Ledford D, Lockey R. Asthma and comorbidities. Curr Opin Allergy Clin Immunol 2013; 13:78-86
39. Kennedy J, Haymann P, Platts-Mills T. The role of allergy in severe asthma. J Clin Exp Allergy 2012; 42:659-669
40. Hoy R. Work related laryngeal syndromes. Curr Opin Allergy Clin Immunol 2012; 12:95-101
41. Boulet L. Cough and upper airway disorders in elite athletes: A critical review. Br J Sports Med 2012; 46:417-421
42. McCabe D, Altman K. Laryngeal hypersensitivity in the world trade centre: Exposed population. Am J Respir Crit Care Med 2012; 186: 402-403
43. Gaziano J, Serrano J. Transferrable skills in the field of speech language pathology. Curr Opin Otolaryngol Head Neck Surg 2012; 20:155-159